Literature DB >> 27167150

Implementation of colorectal cancer screening in Spain: main results 2006-2011.

Dolores Salas Trejo1, Isabel Portillo Villares, Josep A Espinàs Piñol, Josefa Ibáñez Cabanell, Mercedes Vanaclocha Espí, Francisco Pérez Riquelme, Mariola de la Vega Prieto, Álvaro González de Aledo Linos, Isabel Idígoras Rubio, Begoña Sacristán Terroba, Rosa López García, Carmen Romero Hergueta.   

Abstract

The Spanish Cancer Screening Network involves the participation of all regional programmes and has been working for over 20 years to co-ordinate strategies and implement quality assurance in current and new regional programmes. In colorectal cancer, the target population is the group aged 50-69 years, who are offered biennial testing using the faecal occult blood test in all programmes, with follow-up colonoscopy if the faecal occult blood test is positive. This article presents the main trends, indicators and differences by sex. The main indicators from 2006 to 2011 were analysed: coverage, participation rate, positivity rate, colonoscopy uptake and lesions detected. Annual trends were adjusted by sex and region. In 2011, coverage was 9.74% of the Spanish target population. A total of 1 001 669 first invitations were registered from 2006 to 2011 and 596 649 individuals participated in the programmes (43.83% participation rate). Results were positive in 30 544 individuals (5.47%), with the lowest positivity rate occurring in 2007 (3.06%) and the highest in 2011 (6.30%) (P<0.001). In all, 27 568 colonoscopies were registered, with a high compliance rate (90.00% in 2011 and 95.59% in 2007) (P=0.381). The adenoma and colorectal cancer detection rates increased over the period, reaching 32.25/1000 and 3.42/1000 participants in 2011, respectively (P<0.001 and P=0.001). Comparison of differences by sex showed that detection rates were significantly higher in men than in women (P<0.001). Participation increased over time and has now reached an acceptable rate. Men show low participation but higher detection rates, indicating the need for further intervention. The Spanish Cancer Screening Network provides common evaluation, performance and organizational benchmarking.

Entities:  

Mesh:

Year:  2017        PMID: 27167150     DOI: 10.1097/CEJ.0000000000000232

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

1.  Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.

Authors:  Carolina Guiriguet; Guillem Pera; Antoni Castells; Pere Toran; Jaume Grau; Irene Rivero; Andrea Buron; Francesc Macià; Carmen Vela-Vallespín; Mercedes Vilarrubí-Estrella; Mercedes Marzo-Castillejo
Journal:  BMC Cancer       Date:  2017-08-07       Impact factor: 4.430

2.  A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.

Authors:  María Gallardo-Gómez; Sebastian Moran; María Páez de la Cadena; Vicenta Soledad Martínez-Zorzano; Francisco Javier Rodríguez-Berrocal; Mar Rodríguez-Girondo; Manel Esteller; Joaquín Cubiella; Luis Bujanda; Antoni Castells; Francesc Balaguer; Rodrigo Jover; Loretta De Chiara
Journal:  Clin Epigenetics       Date:  2018-04-16       Impact factor: 6.551

3.  Multimorbidity by Patient and Tumor Factors and Time-to-Surgery Among Colorectal Cancer Patients in Spain: A Population-Based Study.

Authors:  Miguel Angel Luque-Fernandez; Daniel Redondo-Sanchez; Shing Fung Lee; Miguel Rodríguez-Barranco; Ma Carmen Carmona-García; Rafael Marcos-Gragera; María-José Sánchez
Journal:  Clin Epidemiol       Date:  2020-01-14       Impact factor: 4.790

4.  Evaluation of productivity losses due to premature mortality from colorectal cancer.

Authors:  Josep Darbà; Alicia Marsà
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

5.  Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.

Authors:  I Idigoras; A Arrospide; I Portillo; E Arana-Arri; L Martínez-Indart; J Mar; H J de Koning; R Lastra; M Soto-Gordoa; M van der Meulen; I Lansdorp-Vogelaar
Journal:  BMC Public Health       Date:  2017-08-01       Impact factor: 3.295

6.  Results after 10 years of colorectal cancer screenings in Spain: Hospital incidence and in-hospital mortality (2011-2016).

Authors:  Josep Darbà; Alicia Marsà
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.